NCT00162318已完成1 期
A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Safe and effective dose of combination of Erbitux and Iressa therapy.
研究概览
简要总结
The purpose of this study is to find a safe and effective dose of Erbitux and Iressa for subject with non small cell lung cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with advanced or metastatic non small cell lung cancer.
- •Subjects should have had at least one prior chemotherapy with a platinum based therapy.
排除标准
- •Subjects are excluded from this study if they do not have non small cell lung cancer that is advanced or metastatic or have not had at least one prior platinum based chemotherapy.
研究组 & 干预措施
A
Experimental
干预措施: Cetuximab + Gefitinib (Drug)
结局指标
主要结局
Safe and effective dose of combination of Erbitux and Iressa therapy.
次要结局
- Response will be measured by radiographic measurement of disease every 4 weeks.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study of Cetuximab in Combination With Tarceva in Patients With Solid TumorsNeoplasmsNCT00207077Eli Lilly and Company33
已完成
2 期
Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerPancreatic CancerNCT00225784Dartmouth-Hitchcock Medical Center37
已完成
1 期
Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7NCT01935921National Cancer Institute (NCI)19
已完成
2 期
Palbociclib and Cetuximab in Metastatic Colorectal CancerCancer of the ColonColon NeoplasmsColonic CancerNeoplasms, ColonicColon CancerNCT03446157UNC Lineberger Comprehensive Cancer Center24
已完成
2 期
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerHead and Neck CancerSquamous Cell CarcinomaNCT00409565National Cancer Institute (NCI)48